PFG
50
-2
PG
50
2
TROW
51
-2
ACN
70
5
ABT
57
-5
KO
44
2
DG
12
2
RSG
77
4
JCI
61
-2
LEN
52
2
KHC
17
4
AAPL
45
3
STZ
58
3
OI
43
-2
SIG
47
-2
INTC
49
16
SWKS
33
-10
NRG
50
-2
WHR
70
4
SYF
93
-2
PFG
50
-2
PG
50
2
TROW
51
-2
ACN
70
5
ABT
57
-5
KO
44
2
DG
12
2
RSG
77
4
JCI
61
-2
LEN
52
2
KHC
17
4
AAPL
45
3
STZ
58
3
OI
43
-2
SIG
47
-2
INTC
49
16
SWKS
33
-10
NRG
50
-2
WHR
70
4
SYF
93
-2
Financhill
Back

Assembly Biosciences 10K Form

Sell
30

ASMB
Assembly Biosciences

Last Price:
16.71
Seasonality Move:
4.26%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ASMB News And Ratings

See the #1 stock for the next 7 days that we like better than ASMB

ASMB Financial Statistics

Sales & Book Value

Annual Sales: $7.16M
Cash Flow: $-17.12M
Price / Cash Flow: 3.58
Annual Sales: $5.47
Price / Book: 3.03

Profitability

EPS (TTM): -8.62000
Net Income (TTM): $-45.61M
Gross Margin: $0
Return on Equity: -111.22%
Return on Assets: -46.52%

Assembly Biosciences Earnings Forecast

Key Assembly Biosciences Financial Ratios

  • The Selling, General & Administrative Expenses for ASMB have been equal to 319.82% of Gross Profit Margin.
  • The Research & Development expenses have been 682.67% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • Per Share Earnings over the last 16 years have been positive in 11 years.

Assembly Biosciences Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: ASMB
CUSIP: 045396
Website: assemblybio.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 2.74
Quick Ratio: 2.65

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ASMB Technical Analysis vs Fundamental Analysis

Sell
30
Assembly Biosciences (ASMB) is a Sell

Is Assembly Biosciences a Buy or a Sell?